Karolinska Development AB
Karolinska Development AB
Karolinska Development AB
Overview
Date Founded
Headquarters
Type of Company
Employees (Worldwide)
Industries
Company Description
Website
Contact Data
In The News
GlobeNewswire
March 1, 2021
Thomson Reuters ONE
September 18, 2020
GlobeNewswire
September 18, 2020
ENP Newswire
September 9, 2020
RelSci
September 4, 2020
Executives & Employees
Chief Executive Officer & Director
Deputy Chief Executive Officer
Chief Scientific Officer
Head of Accounting
Controller
Director
Director
Director
Chief Financial Officer & Investment Director
Analyst
Board of Directors
Executive Chairman at Isogenica Ltd.
Founder at Sino Biopharmaceutical Ltd.
Vice Chairman at Beijing Tide Pharmaceutical Co., Ltd.
Director at Essity AB
Director at Dedicare AB
Director & Vice President-Business Development at Pharmathen International SA
Director at Karolinska Development AB

Owners & Shareholders



Recent Transactions



Transaction Clients
Transaction Advisors
Underwriter
Underwriter
Underwriter
Advisors & Consultants
Key Stats and Financials As of 2020
Market Capitalization
Total Enterprise Value
Earnings Per Share
TEVNet Income
Enterprise Value / Sales
Three Year Compounded Annual Growth Rate Of Revenue
Debt TEV
EBITDAMargin
Revenue
Net Profit
Total Debt
Total Equity
EBITDA
This web site is not endorsed by, directly affiliated with, maintained, authorized, or
sponsored by Karolinska Development AB. The use of any trade name or trademark is for identification and
reference purposes only and does not imply any association with the trademark holder. The
Presence of Karolinska Development AB's profile does not indicate a business or promotional relationship of
any kind between RelSci and Karolinska Development AB.